explore -WSS

explore

author：entertainment 2025-10-01 20:16:21 - browse：927

Nathan Guo, left, and his wife Ada Lio encourage their 17-month-old son, Lucas Guo, to take steps in his gate trainer at their home in Somerville, MA on February 16, 2024. Lucas has one of the world's rarest diseases, ZTTK Syndrome — Lucas Guo, a boy with a rare neurological condition called ZTTK, is encouraged by his father, Nathan Guo, and mother, Ada Lio, to take some steps. Craig F. Walker/The Boston Globe

SOMERVILLE — At 19 months old, Lucas Guo has never crawled, walked, or stood by himself. He babbles but can’t say words. He struggles to chew and swallow. He gets most of his nutrition through a feeding tube attached to his belly.

Lucas has one of the world’s rarest diseases, ZTTK syndrome, a complex neurological disorder caused by a genetic mutation. Scientists have documented only about 60 cases worldwide and estimate that, at most, it afflicts several hundred people — far too few to encourage drug makers to find a treatment.

That economic reality has driven Lucas’s parents, Ada Lio and Nathan Guo, to take things into their own hands. Working through a small foundation, they are trying to raise $10 million to develop a treatment or cure for ZTTK in five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Awakening the world to the whoosh: A patient's crusade

hotspot

knowledge

focus

WSS

Awakening the world to the whoosh: A patient's crusade

Experts study whether long Covid risk adds up with each reinfection

Health insurers' Q3 question: how much care are people getting?

Winning ticket for $1 billion Powerball jackpot sold in California

European officials brace for rough respiratory virus season

Mass General totes up its waste in a move to tackle climate change

knowledge

explore

focus

Guidelines to prevent youth baseball injuries need more muscle

Setback for rare diseases as Taysha Gene Therapies pulls back

In age of alternative facts, a scholarly course on calling out crap

WHO recommends second malaria vaccine

Hepatitis C has a cure — but many Americans still lack access to it

Setback for rare diseases as Taysha Gene Therapies pulls back

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Indian pharmaceutical industry in denial over drug

Dobbs anniversary: the lost opportunity of abortion as health care

CRISPR base editing slashes cholesterol levels in monkeys

knowledge

Mass General totes up its waste in a move to tackle climate change

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Flu, Covid vaccination rates decline, new survey data show

Study points to new risk in gene therapy death of Terry Horgan

Stop Congress from blocking public access to science

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

hotspot

knowledge

focus

entertainment